Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

CzechiaBack to Czechia

Clinical trials in Vratimov

1 clinical trial in Vratimov, Czechia. Every trial is listed in the EU Clinical Trials Register and updated daily.

CzechiaOur site in CzechiaKlinickeTesty.cz(opens in a new tab)
Vratimov at a glance
1
clinical trial
  • Not yet recruiting0
  • Paediatric trials0
  • Research sites0
Type of trial
Recruitment status
Quick filters

1 trial in Vratimov

Open in trial search

Arteriosclerosis

Recruiting
Investigational
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Sponsor:AstraZeneca AB

Other cities in Czechia

The busiest research cities in the country

All 158 cities in Czechia

Clinical research in Vratimov

What the registry says about research in the country

01 Vratimov
Cardiovascular Diseases
Clinical trial activity in Vratimov includes research in cardiovascular diseases, with a focus on people who have atherosclerotic cardiovascular disease or are at high risk of serious heart and vascular events. The studies are designed to assess whether new treatment approaches can better reduce major complications such as heart attack, stroke, and other urgent vascular problems. Testing a new therapy for reducing serious cardiovascular events Studying outcomes in atherosclerotic cardiovascular disease Evaluating protection against heart, stroke, and vascular complications These trials are part of an active recruitment effort, reflecting continued interest in improving prevention and long-term care for patients with cardiovascular risk.
Nutritional and Metabolic Diseases
Another key area of research in Vratimov is nutritional and metabolic diseases, especially obesity and overweight. The trials are exploring whether new treatment options can improve broader health outcomes and lower the risk of illness and death in adults living with excess body weight. Evaluating treatment effectiveness in obesity Researching health outcomes linked to overweight and metabolic risk Assessing whether a new therapy can reduce morbidity and mortality This research highlights the growing role of metabolic care in clinical trials, with an emphasis on improving patient well-being beyond weight management alone.
Back to CzechiaAll countries
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.